TABLE 1.
Persisting symptoms | OR (95% CI) | p‐Value | ||
---|---|---|---|---|
Yes | No | |||
All, N = 137 | 23 (16.8%) | 114 (83.2%) | ||
According to acute symptoms | ||||
Symptomatic, N = 99 | 21 (21.2%) | 78 (78.8%) | 4.80 (1.08–4.49) | .038 |
Asymptomatic, N = 38 | 2 (5.3%) | 36 (94.7%) | ||
According to hospitalisation | ||||
Hospitalised, N = 19 | 6 (31.6%) | 13 (68.4%) | 2.72 (0.74–9.04) | .092 |
Not hospitalised, N = 118 | 17 (14.4%) | 101 (85.6%) | ||
According to age group | ||||
<3 m, N = 4 | 1 (25.0%) | 3 (75.0%) | .179 | |
3 m–1 y, N = 4 | 0 (0.0%) | 4 (100.0%) | ||
1–3 y, N = 10 | 0 (0.0%) | 10 (100.0%) | ||
3–6 y, N = 18 | 2 (11.1%) | 16 (88.9%) | ||
6–10 y, N = 25 | 3 (12.0%) | 22 (88.0%) | ||
10–14 y, N = 50 | 8 (16.0%) | 42 (84.0%) | ||
14–16 y, N = 26 | 9 (34.6%) | 17 (65.4%) |